Showing results (1-10 of 650) with videos related to
Sort By:
Pageof 65
Expert Review of Respiratory Medicine|February 20, 2016
The clinical management of lower respiratory tract infectionsAdamantia Liapikou, Antoni TorresExpert Opinion on Emerging Drugs|July 16, 2013
Emerging drugs on methicillin-resistant Staphylococcus aureusAdamantia Liapikou, Antoni TorresExpert Opinion on Emerging Drugs|June 28, 2016
Emerging drugs for nosocomial pneumoniaAdamantia Liapikou, Antoni TorresExpert Opinion on Pharmacotherapy|May 19, 2012
Levofloxacin for the treatment of respiratory tract infectionsAntoni Torres, Adamantia LiapikouExpert Opinion on Drug Safety|June 27, 2015
Managing the safety of inhaled corticosteroids in COPD and the risk of pneumoniaAdamantia Liapikou, Michael Toumbis, Antoni TorresExpert Opinion on Investigational Drugs|September 28, 2017
Investigational drugs in phase I and phase II clinical trials for the treatment of community-acquired pneumoniaAdamantia Liapikou, Catia Cillóniz, Antoni TorresExpert Review of Anti-Infective Therapy|June 26, 2019
Emerging strategies for the noninvasive diagnosis of nosocomial pneumoniaAdamantia Liapikou, Catia Cillóniz, Antoni TorresExpert Opinion on Drug Safety|September 11, 2018
Drugs that increase the risk of community-acquired pneumonia: a narrative reviewAdamantia Liapikou, Catia Cilloniz, Antoni TorresInfectious Disease Clinics of North America|February 13, 2013
What is the best approach to the nonresponding patient with community-acquired pneumonia?Salvador Sialer, Adamantia Liapikou, Antoni TorresExpert Review of Respiratory Medicine|May 20, 2014
The management of severe community acquired pneumonia in the intensive care unitAdamantia Liapikou, Edmundo Rosales-Mayor, Antoni TorresPageof 65